We demonstrated for the first time that SPRC was able to suppress cell proliferation and migration and also tumor growth in gastric cancer-induced model of nude mice, indicating that it may be a potential agent for the treatment of gastric cancer in humans. This evidence concerns the gene SPRR3 and gastric cancer.